Major M&A Bookends Year Of Mainly Steady Growth For Leading Medtech Groups

In Vivo's latest rankings of the top 100 revenue earners in the medical technology industry show the groups leading the global market tightening their grip further in 2017. This was partly a function of providers choosing to partner more and more with fewer suppliers who can offer a wider provision of services. But it was steady as she goes for most of the multinational medtechs, with some major exceptions, and there will be more M&A reflected in next year's rankings, based on 2018 revenues.

Businessmen
• Source: Shutterstock

For companies leading the global medical technology industry, the sales rankings this year were strikingly similar to the last – with a handful of major exceptions – two of which affected the leading 10 global companies. These 10 companies all recorded sales of over $10 billion, with the acquisitive Boston Scientific Corp. (electrophysiology company Apama Medical being its only major buy in 2017) now knocking on the door of that exclusive club after seriously adding to its sales mix with a string of strategic buys in 2018.

Medtronic PLC led the field in terms of sales once more in 2017, but did not quite become history's...

More from Outlook Archive

More from Outlook